PRAC meeting highlights 23-26 October 2023
23/10/2023
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
The current PRAC highlights from the October 2023 meeting outlines the PRAC's position that the available evidence does not support a link between GLP-1 receptor agonists and thyroid cancer.